Press Ganey (PGND) and NantHealth (NH) Head to Head Analysis

Press Ganey (NYSE: PGND) and NantHealth (NASDAQ:NH) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation.

Institutional & Insider Ownership

91.9% of Press Ganey shares are held by institutional investors. Comparatively, 7.1% of NantHealth shares are held by institutional investors. 5.1% of Press Ganey shares are held by insiders. Comparatively, 58.0% of NantHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Press Ganey and NantHealth’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Press Ganey N/A N/A N/A $0.51 79.41
NantHealth $100.38 million 3.80 -$184.10 million ($1.46) -2.41

Press Ganey has higher earnings, but lower revenue than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than Press Ganey, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings for Press Ganey and NantHealth, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Press Ganey 0 0 0 0 N/A
NantHealth 0 0 4 0 3.00

NantHealth has a consensus price target of $9.00, suggesting a potential upside of 155.68%. Given NantHealth’s higher possible upside, analysts plainly believe NantHealth is more favorable than Press Ganey.


This table compares Press Ganey and NantHealth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Press Ganey 8.69% 5.46% 3.34%
NantHealth -225.76% -46.09% -25.23%


Press Ganey beats NantHealth on 6 of the 10 factors compared between the two stocks.

Press Ganey Company Profile

Press Ganey Holdings, Inc. is a provider of patient experience and caregiver measurement, performance analytics and strategic advisory solutions for healthcare organizations. The Company provides its clients with a digital platform that captures the perspectives of patients, physicians, nurses and other healthcare employees and enables its clients to benchmark, analyze and manage the patient and caregiver experience. Its solutions include Patient Experience Solutions, which include Patient experience measurement, insights and advisory services; Caregiver Engagement Solutions, which include Physician, nurse and employee engagement measurement, insights and advisory services; Clinical and Quality Solutions, which include nursing quality indicators, patient reported outcome measures, core measures and eMeasures, and Consulting Solutions, which include patient safety and care reliability, patient experience improvement, process flow, advanced analytics and insights and cultural alignment.

NantHealth Company Profile

NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

Receive News & Ratings for Press Ganey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Press Ganey and related companies with's FREE daily email newsletter.

Leave a Reply